Arax Advisory Partners
LENZ icon

Arax Advisory Partners’s LENZ Therapeutics LENZ Stock Holding History

Arax Advisory Partners’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Buy
4,458
+4,432
+17,046% +$35.7K ﹤0.01% 3792
2026
Q1 		$238 Buy
+26
New +$365 ﹤0.01% 3516
2025
Q4 		– Sell
-55
Closed -$2.56K – 4586
2025
Q3 		$2.56K Buy
+55
New +$2.02K ﹤0.01% 3051
2024
Q4 		– Sell
-12
Closed -$285 – 2788
2024
Q3 		$285 Hold
12
– – ﹤0.01% 2479
2024
Q2 		$208 Buy
+12
New +$210 ﹤0.01% 2434

Other funds holding LENZ

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Arax Advisory Partners's LENZ Position: Q2 2026 in Review

Arax Advisory Partners increased its LENZ Therapeutics (LENZ) stake by 17,046% in Q2 2026, buying an estimated $35.7K and bringing the position to 4,458 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3792.

Arax Advisory Partners first reported a position in LENZ in Q2 2024 and has held it in 5 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Arax Advisory Partners held 4,458 shares of LENZ Therapeutics worth $25.3K as of Q2 2026.
  • Arax Advisory Partners bought 4,432 LENZ Therapeutics shares in Q2 2026, an estimated $35.7K.
  • LENZ Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3792 holding.
  • Arax Advisory Partners first reported a position in LENZ Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.